STOCK TITAN

SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
SOPHiA GENETICS (NASDAQ: SOPH) CEO Jurgi Camblong, PhD., to present at J.P. Morgan 2024 Healthcare Conference on January 11, 2024, in San Francisco.
Positive
  • None.
Negative
  • None.

BOSTON and ROLLE, Switzerland, Dec. 14, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (NASDAQ: SOPH) today announced that Jurgi Camblong, PhD., Chief Executive Officer and Co-founder, is scheduled to present at the J.P. Morgan 2024 Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PST in San Francisco.

Live, listen-only webcasts of this presentation can be accessed by visiting the Investors section of the SOPHiA GENETICS website at ir.sophiagenetics.com. A replay of the webcast will be available shortly after the conclusion of the presentation and archived on the company's website for two weeks following the presentation.

About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on XLinkedInFacebook, and Instagram. Where others see data, we see answers. 

Investor Contact:
Kellen Sanger
ir@sophiagenetics.com

Media Contact:
Kelly Katapodis
media@sophiagenetics.com


FAQ

When is Jurgi Camblong, CEO of SOPHiA GENETICS, presenting at the J.P. Morgan 2024 Healthcare Conference?

Jurgi Camblong, CEO of SOPHiA GENETICS, is scheduled to present at the J.P. Morgan 2024 Healthcare Conference on Thursday, January 11, 2024, at 9:00 a.m. PST in San Francisco.

How can I access the live webcast of the presentation by Jurgi Camblong, CEO of SOPHiA GENETICS, at the J.P. Morgan 2024 Healthcare Conference?

The live, listen-only webcasts of the presentation can be accessed by visiting the Investors section of the SOPHiA GENETICS website at ir.sophiagenetics.com.

Will there be a replay of the webcast of the presentation by Jurgi Camblong, CEO of SOPHiA GENETICS, at the J.P. Morgan 2024 Healthcare Conference?

Yes, a replay of the webcast will be available shortly after the conclusion of the presentation and archived on the company's website for two weeks following the presentation.

SOPHiA GENETICS SA Ordinary Shares

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Stock Data

329.12M
46.15M
5.92%
49.96%
0.08%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
Rolle

About SOPH

sophia genetics, world's largest clinical genomics community, brings together expertise in genetics, bioinformatics, machine learning and genomic privacy. based in switzerland, we are known for our high medical standards and swiss precision. sophia genetics offers health professionals who perform clinical genetic testing unparalleled bioinformatics analysis, quality assurance and secure banking of patient dna sequence data generated by ngs. the company helps clinical laboratories to reduce costs, overcome complexity, significantly improve the turnaround time for routine diagnosis and meet quality requirements related to the use of ngs in the clinic. our solution, the sophia ddm™ platform allows hospitals to better and faster diagnose patients using cutting edge ngs analytics algorithms and through knowledge sharing within the largest clinical genomics community in the world (+100 hospitals). the name « sophia » means wisdom in greek and it is the definition of our excellence based